Fatal Interstitial Lung Disease Associated With Erlotinib: A Case Report and Review of Literature
نویسندگان
چکیده
1Department of Pathology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China 2Department of Radiology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China 3Department of Nuclear Medicine, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China 4Department of Respiratory Medicine, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China Case Report Open Access
منابع مشابه
Erlotinib Induced Fatal Interstitial Lung Disease in a Patient with Metastatic Non-Small Cell Lung Cancer: Case Report and Review of Literature
Erlotinib is one of the most widely used tyrosine kinase inhibitor targeting human epidermal growth factor receptor. Since its introduction, it has revolutionized the treatment of advanced non-small cell lung cancer. Skin rashes and diarrhea are the most often reported side effects of erlotinib however it is also associated with interstitial pneumonitis or interstitial lung disease, which often...
متن کاملErlotinib-associated near-fatal interstitial pneumonitis in a patient with relapsed lung adenocarcinoma.
Erlotinib (Tarceva) is a human epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used for treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen. Interstitial lung disease, associated with gefitinib (Iressa) use, has been reported in approximately 1% of patients worldwide. However, the adverse pulmo...
متن کاملa 2.5 months old girl with interstitial lung disease-a case report
Children interstitial lung (ChILD) disease is a large group of disorders with damage in alveolus and capillary. Although these disorders resemble ILD of adult in nomination, ChILD represents different pathologic and clinical patterns. A 2.5 months old girl, with failure to thrive and grunting and dyspnea, complained of staccato coughs without association with feeding, since she was 15 days o...
متن کاملErlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease
Interstitial lung disease (ILD) induced by epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib and erlotinib, is a rare but fatal complication of TKI treatment. Transfer to chemotherapy or continuation with TKI of reduced dose are alternative treatment strategies. We report a case of severe ILD in a non-small cell lung cancer patient treated with gefitinib...
متن کاملFatal asymmetric interstitial lung disease after erlotinib for lung cancer.
Pulmonary toxicity is a known complication of erlotinib, one of the epidermal growth factor receptor tyrosine kinase inhibitors. It consists of diverse entities such as interstitial pneumonitis, bronchiolitis obliterans with organizing pneumonia and pulmonary fibrosis. In our report, an unusual case of an asymmetric interstitial lung disease was described. A 68-year-old female presented with re...
متن کامل